Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Medical Distribution


Interviews

Canada’s top edible cannabis producer eyes further growth

Medicus Pharma advances cancer treatment towards phase II trial

Emerging opportunity in a growing, high-value dermatological market

Pharmaceutical company treats bladder cancer with new tech

Press Releases

Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income From Operations

  Apr 25, 2024

Antibe Announces Appointment of Receiver

  Apr 24, 2024

DoorDash and Walgreens Launch Unprecedented Access for SNAP Customers

  Apr 24, 2024

TUESDAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in Ventyx Biosciences, Inc. with...

  Apr 25, 2024

Medical Facilities Corporation to Announce First Quarter 2024 Financial Results on May 9, 2024

  Apr 25, 2024

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of...

  Apr 25, 2024

HLS Therapeutics to Host Q1 Fiscal 2024 Financial Results Conference Call

  Apr 25, 2024

Assertio Holdings, Inc. to Report First Quarter 2024 Financial Results on May 6, 2024

  Apr 25, 2024

ProPhase Labs to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 &...

  Apr 25, 2024

Aquestive Therapeutics to Report First Quarter 2024 Financial Results and Recent Business Highlig...

  Apr 25, 2024

Collegium to Report First Quarter 2024 Financial Results on May 9, 2024

  Apr 25, 2024

MediWound to Present New Data from EscharEx® Phase II Studies at Three Leading Wound Care...

  Apr 25, 2024

American Oncology Cares Foundation Expands Non-Medical Financial Support to Local Cancer Patients...

  Apr 25, 2024

Tilray Brands Celebrates Epic 420 Weekend With Over 20,000 Fans Across the U.S.

  Apr 25, 2024

Optinose Provides Corporate Update on XHANCE Launch and Outlook and Announces Preliminary First...

  Apr 25, 2024

Bristol Myers Squibb Reports First Quarter Financial Results for 2024

  Apr 25, 2024

Jushi Holdings Inc. to Report First Quarter 2024 Financial Results on May 9, 2024

  Apr 25, 2024

Oncolytics Biotech® Announces Upcoming Presentations at the American Society of Clinical...

  Apr 25, 2024

Theralase(R) Closes $CAN 750,000 Non-Brokered Private Placement

  Apr 24, 2024

Kymera Therapeutics to Report First Quarter 2024 Financial Results on May 2

  Apr 25, 2024

Regeneron and Mammoth Biosciences Collaborate to Pursue Next-Generation CRISPR-Based Gene Editing...

  Apr 25, 2024

TELA Bio to Announce First Quarter 2024 Financial Results

  Apr 25, 2024

GRI Bio to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar

  Apr 25, 2024

Integer Holdings Corporation Reports First Quarter 2024 Results

  Apr 25, 2024

Aclarion's Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the...

  Apr 25, 2024

FibroBiologics Plans to Collaborate with Charles River to Manufacture Fibroblast-based Spheroids

  Apr 25, 2024

iSpecimen to Report First Quarter 2024 Financial Results on May 7, 2024

  Apr 25, 2024

Candel Therapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting

  Apr 25, 2024

UNITY Biotechnology Announces Upcoming Presentations at the ARVO 2024 Annual Meeting

  Apr 25, 2024

Elicio Therapeutics to Present New Preliminary Data from the Ongoing AMPLIFY-7P Phase 1/2 Study...

  Apr 25, 2024

Autonomix Enters into Agreement with NoiseFigure Research, Inc. to Develop Next Generation of its...

  Apr 25, 2024

Apollomics Announces Approval of Vebreltinib in China as a First-in-Class Treatment for Gliomas...

  Apr 25, 2024

Theriva(TM) Biologics to Discuss the Trial Design for VIRAGE - a Phase 2b Clinical Study of...

  Apr 25, 2024

Streamline Health® Signs Second Enterprise Client

  Apr 25, 2024

Kura Oncology to Report First Quarter 2024 Financial Results

  Apr 25, 2024

XOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One's OJEMDATM (tovoraf...

  Apr 25, 2024

AIM ImmunoTech Announces Release of the Next CEO Corner Segment

  Apr 25, 2024

Co-Diagnostics, Inc. Announces First Quarter 2024 Earnings Release Date and Webcast

  Apr 25, 2024

HOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for HB-200 in Combination with Pembrolizumab

  Apr 25, 2024

BioVie Presents Data Showing Potential for Bezisterim (NE3107) to Reduce Inflammation and Restore...

  Apr 25, 2024

Aligos Therapeutics Mourns the Passing of MASH Industry Leader Stephen A. Harrison, MD

  Apr 25, 2024

Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and...

  Apr 25, 2024

Sensus Healthcare Issues Reminder That its First Quarter 2024 Financial Results and Business...

  Apr 25, 2024

Compass Therapeutics Receives FDA Fast Track Designation for the Investigation of CTX-009 in...

  Apr 25, 2024

Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements

  Apr 25, 2024

GDRX INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that GoodRx Holdings, Inc....

  Apr 25, 2024

Soligenix Extends Patent Protection for its Filovirus Vaccine Platform to the United Kingdom and...

  Apr 25, 2024

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of...

  Apr 25, 2024

INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp....

  Apr 25, 2024

Wheel to Power Owlet's New Virtual Health and Prescription Service

  Apr 25, 2024

Acurx Pharmaceuticals Announces Presentation of Ibezapolostat Phase 2 Clinical Trial Results at...

  Apr 25, 2024

More

Agriculture Building Materials Cannabis Chemicals Coal Communication Services Consumer Cyclical Consumer Defensive Energy Financial Services Forest Products Healthcare Industrials Metals & Mining Gold Industrial Metals & Minerals Silver Real Estate Steel Technology Utilities